Navigation Links
Lineagen and Fast Forward Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis

SALT LAKE CITY, Dec. 14, 2011 /PRNewswire/ -- Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, today announced an alliance to fund the clinical development and validation of a blood-based assay for multiple sclerosis (MS). The goal of the program is to develop a test that can aid clinicians in diagnosing MS, distinguishing it from other neurological disorders, and providing the prognostic information needed to help guide treatment decisions and response to therapies.

Under the terms of the Sponsored Research Agreement, Fast Forward is committing $622,000 to establish and validate a broad array of biomarkers for MS, including genes associated with predisposition to the disease and blood based markers that have diagnostic and prognostic potential. The funding will support an ongoing clinical program that is being conducted under the teams of John W. Rose, M.D., Professor of Neurology at the University of Utah and Mark Leppert, Ph.D., Professor of Human Genetics at the University of Utah.

"We are pleased to partner with Lineagen in the advancement of its innovative technology for MS," said Timothy Coetzee, Ph.D., Chief Research Officer of the National MS Society. "Fast Forward's partnership with Lineagen reflects our commitment to create new tools and technology to assist physicians in making diagnostic and treatment decisions that will improve the quality of life for people living with this disease."

Michael S. Paul, Ph.D., Lineagen's President and Chief Executive Officer, stated, "It is a great opportunity for Lineagen to collaborate with Fast Forward and the National MS Society. This collaboration will enhance the development and validation of our proprietary gene and biomarker-based assay in MS.  The funding from Fast Forward will accelerate this clinical program, allowing the collaborative team to evaluate and affirm a broad number of biomarkers simultaneously, with the collective goal of delivering our best testing services to physicians and patients."

Dr. Rose commented, "One of the most critical challenges is to find answers to key questions, such as how do we identify those patients who are more likely to experience disease progression and how do we determine patients' potential responsiveness to therapy? With this important funding provided by Fast Forward, we will rapidly gain key insights that we believe can have a profound impact on the lives of people living with MS."

About MS

MS is a chronic, unpredictable neurological disease that affects the central nervous system. It is thought to be an autoimmune disorder, meaning the immune system incorrectly attacks healthy tissue. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. These problems may be permanent or may come and go. According to the National MS Society, at least 400,000 Americans have MS, and every hour someone is newly diagnosed. MS affects about 2.1 million people worldwide.

About Lineagen

Lineagen, based in Salt Lake City, sells integrated diagnostic and consultative services for complex disorders to physicians, combining high-value genetic testing with comprehensive, personalized consultative services.

Lineagen is strongly differentiated through its focus on specific complex diseases and disorders with demonstrated genetic association: autism spectrum disorders (ASD), multiple sclerosis (MS) and chronic obstructive pulmonary disorder (COPD). This specialization enables the company to combine powerful insight into clinical diagnostic pathways with strong proprietary and in-licensed research data, resulting in earlier, more personalized intervention and management for conditions where genetic susceptibility matters. Lineagen addresses a large, unmet, and growing need for expert genetic testing and counseling services designed to support community physicians and families.

For additional information, please visit  

About Fast Forward, LLC

Fast Forward, LLC is a nonprofit organization established by the National Multiple Sclerosis Society in order to accelerate the development of treatments for MS. Fast Forward will accomplish its mission by connecting university-based MS research with private-sector drug development and by funding small biotechnology/pharmaceutical companies to develop innovative new MS therapies and repurpose FDA-approved drugs as new treatments for MS. More information can be found at

About The National Multiple Sclerosis Society

The National MS Society addresses the challenges of each person affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, collaborating with MS organizations around the world, and providing programs and services designed to help people with MS and their families move their lives forward. We are people who want to do something about MS now, and are dedicated to achieving a world free of MS. Join the movement at

Lineagen, Inc.
Justin Jackson
Burns McClellan
Tel: (212) 213-0006

National MS Society and Fast Forward, LLC
Arney Rosenblat
Associate Vice President, Public Affairs, National MS Society
Tel: (212) 476-0436

(Logo: )



SOURCE Lineagen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ProAmatine® (midodrine HCl) Update: Path Forward Agreed
2. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
3. Bluestar Silicones Moves Forward with Growth Plans; Completes Acquisition of Facility in South Carolina
4. Craneware Supports Forward-Thinking Community Hospital Executives to Strengthen U.S. Community Healthcares Business Performance
5. Pharmasset Announces Two-for-One Forward Stock Split
6. TV Favourite Jo Brand Puts Her Best Foot Forward for Macmillan Cancer Support
7. Continuity as Debiopharm Group™ Management Moves Forward
8. Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward
9. Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
10. Miami HEAT Forward Juwan Howard and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health
11. Sunridge Moves Forward to Open Company Owned Clinics
Post Your Comments:
(Date:10/9/2015)... , October 9, 2015 /PRNewswire/ ... --> The report summarizes ... and overall status of the manufacturers ... guidance and direction for companies and ... . --> ...
(Date:10/9/2015)... PHILADELPHIA , October 9, 2015 ... Conference, Oct. 7-9   ... information products and services, today launched ClinicalKey for Nursing ... authoritative content, tailored to meet the unique needs of nursing ... in Atlanta , Oct. 7-9, will have ...
(Date:10/9/2015)... 2015  Hi-Tech Pharmaceuticals ("Hi-Tech"), a leading global ... iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition ... , today announced that they have entered into ... to acquire iForce. The transaction will enhance Hi-Tech,s ... through iForce,s strong distribution network. Jared ...
Breaking Medicine Technology:
... BETHLEHEM, Pa., April 28, 2011 Particle Sciences ... EVA Performance Polymers, a leading supplier of ethylene ... together to streamline the development of drug-eluting devices. ... Celanese EVA Performance Polymers are working to provide ...
... A new study published online today in The ... (Avastin) is as effective as ranibizumab (Lucentis), the current ... degeneration (AMD). The results are from ... a pioneering comparative effectiveness trial made possible through funding ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... The Bank of America 500 NASCAR Sprint Cup ... Saturday, October 10th, defending race winner, Kevin Harvick, will battle it out for the ... and all of the stars of the NASCAR Sprint Cup Series. As part ...
(Date:10/10/2015)... ... October 10, 2015 , ... In the inaugural people’s choice contest, entitled Bold ... Work in Jacksonville, amongst medium-sized companies with 25 – 99 employees. The announcement was ... a celebratory gala on October 1st. , Many of the features of the ...
(Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack ... footage. A LUT is a Lookup Table that contains a mathematical formula for modifying ... the table. This pack comes with 60 vibrant CUBE LUT files. , ...
(Date:10/9/2015)... CA (PRWEB) , ... October 09, 2015 , ... ... now offering a special promotion on Invisalign, the orthodontic system that uses clear, ... The aligners are almost invisible against the teeth, which allow patients to complete ...
(Date:10/9/2015)... ... 09, 2015 , ... Confidence Plus Insurance has just celebrated ... initiative that involves working with a series of local charities throughout the California ... Insurance is the Gleason Park Electric Violin Ensemble (GPEVE). , GPEVE provides a ...
Breaking Medicine News(10 mins):
... , New Report Highlights Best and Worst State ... Va., Sept. 10 A new report by The Vision Council, ... for children entering school are inconsistent, impeding children,s ability to succeed ... visual processing of information, undetected vision problems can severely impact a ...
... largest network of Hispanic health advocates joins President Obama,s efforts to improve ... , WASHINGTON, Sept. 9 "There was a clear ... reform. We need to work together to get the job done and ... our history, it is essential that we do this to support America,s ...
... , Statement attributable to: J. James Rohack, M.D. President, ... that Medical Liability Reform is Needed , , ... is unacceptable. The AMA will continue to work for reform that makes ... opportunity this year to achieve meaningful health reform for America,s patients and ...
... Sept. 9 In commemoration of the first September 11 National ... Los Angeles will host three 2-hour volunteer orientations for 100+ youth and ... tour of the chapter,s new state of the art Emergency Operation Center, ... recent California wildfires. , , What: ...
... MECHANICSBURG, Pa., Sept. 9 Select Medical Holdings ... the launch of its initial public offering of 33,333,333 shares ... is expected to be between $11.00 and $13.00 ... of common shares by Select, and Goldman, Sachs & Co., ...
... 9 As the nation awaits President Obama,s address on ... Philanthropic Collaborative (TPC) sent today a letter to the President ... foundations in the field of health. , , ... the social and economic effectiveness of health-related philanthropic activities. ...
Cached Medicine News:
CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
Bras and Breast Support...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
Medicine Products: